Document is current
Any future updates will be listed below
-
Authors
Roider, Tobias https://orcid.org/0000-0002-6973-3531
Baertsch, Marc A. https://orcid.org/0000-0002-4000-6904
Fitzgerald, Donnacha https://orcid.org/0000-0003-4927-7484
Vöhringer, Harald https://orcid.org/0000-0003-2513-4518
Brinkmann, Berit J. https://orcid.org/0000-0002-0457-2159
Czernilofsky, Felix
Knoll, Mareike
Llaó-Cid, Laura https://orcid.org/0000-0003-0543-6084
Mathioudaki, Anna https://orcid.org/0000-0003-4617-7015
Faßbender, Bianca
Herbon, Maxime
Lautwein, Tobias
Bruch, Peter-Martin https://orcid.org/0000-0002-9992-3109
Liebers, Nora
Schürch, Christian M. https://orcid.org/0000-0002-1792-1768
Passerini, Verena
Seifert, Marc
Brobeil, Alexander
Mechtersheimer, Gunhild
Müller-Tidow, Carsten https://orcid.org/0000-0002-7166-5232
Weigert, Oliver https://orcid.org/0000-0002-0987-7373
Seiffert, Martina
Nolan, Garry P. https://orcid.org/0000-0002-8862-9043
Huber, Wolfgang https://orcid.org/0000-0002-0474-2218
Dietrich, Sascha https://orcid.org/0000-0002-0648-1832
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung
Hairy Cell Leukemia Foundation
Heidelberg Research Centre for Molecular Medicine
Universität Heidelberg
European Molecular Biology Laboratory
National Center for Tumor Diseases (NCT) Heidelberg
Else Kröner-Fresenius-Stiftung
Deutsche Forschungsgemeinschaft
- License Information
-
More Information
Article History
Received: 21 March 2023
Accepted: 15 January 2024
First Online: 20 February 2024
Competing interests
: C.M.S. is a scientific advisor to, has stock options in and has received research funding from Enable Medicine, Inc. G.P.N. is a co-founder and stockholder of Akoya Biosciences, Inc. and inventor on patent US9909167 (On-slide staining by primer extension). The remaining authors declare no competing interests.
